by Reaction Biology | Sep 10, 2024 | News
Heidelberg, Germany September 10, 2024 – Bioassay GmbH, a leading provider of bioanalytical testing solutions, is pleased to announce that it has successfully obtained a veterinary Good Manufacturing Practice (GMP) license according to Art. 88 of Regulation (EU)...
by Reaction Biology | Apr 3, 2024 | News
~ Reaction Biology will also present 15 posters and exhibit at Booth #141 in the Exhibit Hall ~ Malvern, PA, April 3, 2024 – Reaction Biology (“Reaction” or the “Company”), an industry-leading provider of drug discovery and development services, today announced...
by John Hewitt | Apr 12, 2023 | News
~ New Data will be Presented on the Company’s Innovative Assay Technologies, Preclinical Profiling Models and Proprietary Screening Platforms ~ ~ Reaction Biology will be at Booth #1527 in the AACR 2023 Exhibit Hall ~ Malvern, PA – April 12, 2023 – Reaction Biology...
by John Hewitt | Dec 19, 2022 | News
Malvern, PA, December 19, 2022 – Reaction Biology Corporation (“Reaction”), an industry-leading provider of drug discovery services, today announced that it has been selected to participate as a Specialized Center in the Chemical Biology Consortium (CBC), the...
by John Hewitt | Dec 2, 2022 | News
~ Bioassay GmbH, an Independent Contract Laboratory, Specializes in the Development, Validation and Routine Performance of Bioanalytical Assays ~ ~ Transaction Includes Acquisition of Bioassay GmbH Subsidiary, Peptide Specialty Laboratories GmbH, a Provider...
by John Hewitt | Nov 3, 2022 | News
~ Reaction Biology Acquires the Hershey, Pennsylvania-Based U.S. Operations of Vyant Bio Subsidiary vivoPharm PTY Ltd ~ ~ Transaction Expands Reaction Biology’s Capabilities to Provide Customers with Solutions in Both the Discovery and Development of New Drug...
